| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |